Two Sigma Investments’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.91M | Buy |
1,167,813
+15,187
| +1% | +$76.8K | 0.01% | 1100 |
|
|
2025
Q1 | $6.1M | Sell |
1,152,626
-507,883
| -31% | -$2.69M | 0.01% | 978 |
|
|
2024
Q4 | $11.2M | Buy |
1,660,509
+63,211
| +4% | +$427K | 0.02% | 657 |
|
|
2024
Q3 | $10.5M | Buy |
1,597,298
+171,056
| +12% | +$1.13M | 0.02% | 697 |
|
|
2024
Q2 | $10.7M | Buy |
1,426,242
+529,762
| +59% | +$3.97M | 0.02% | 644 |
|
|
2024
Q1 | $8.94M | Buy |
896,480
+363,840
| +68% | +$3.63M | 0.02% | 654 |
|
|
2023
Q4 | $5.25M | Buy |
532,640
+140,315
| +36% | +$1.38M | 0.01% | 909 |
|
|
2023
Q3 | $3M | Buy |
+392,325
| New | +$3M | 0.01% | 1090 |
|
|
2023
Q2 | – | Sell |
-208,143
| Closed | -$1.39M | – | 3143 |
|
|
2023
Q1 | $1.39M | Buy |
208,143
+135,040
| +185% | +$901K | ﹤0.01% | 1606 |
|
|
2022
Q4 | $564K | Buy |
+73,103
| New | +$564K | ﹤0.01% | 1914 |
|
|
2022
Q2 | – | Sell |
-200,131
| Closed | -$1.43M | – | 2814 |
|
|
2022
Q1 | $1.43M | Buy |
+200,131
| New | +$1.43M | ﹤0.01% | 1473 |
|